2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults

G.B. John Mancini, Eileen O’Meara, Shelley Zieroth, Mathieu Bernier, Alice Cheng, David Z.I. Cherney, Kim A. Connelly, Justin A. Ezekowitz, Ronald Goldenberg, Lawrence A. Leiter, Gihad Nesrallah, Breay W. Paty, Marie‐Ève Piché, Peter Senior, Abhinav Sharma, Subodh Verma, Vincent Woo, Pol Darras, Jonathan Y. Gabor, Jean‐Claude Grégoire, Eva Lonn, James A. Stone, Jean‐François Yale, Colin Yeung, Deborah Zimmerman